SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-21-000184
Filing Date
2021-02-12
Accepted
2021-02-12 17:07:21
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss192044_sc13ga.htm SC 13G/A 61334
2 JOINT FILING AGREEMENT ss192044_ex99a.htm EX-99.A 12501
  Complete submission text file 0000947871-21-000184.txt   75627
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Subject) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87112 | Film No.: 21629313
SIC: 2834 Pharmaceutical Preparations